Evolent Health Inc (EVH)
Healthcare
Health Information Services
3.10 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Evolent Health Inc (EVH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.6% of the shares are freely tradable; institutional investors hold 101.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
101.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
83.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
13.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
113Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 9.68 | 10,888,872 | +5.4 | 03/31/2026 |
| Cadian Capital Management LP | 9.61 | 10,814,473 | -2.4 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 8.07 | 9,081,079 | -2.1 | 03/31/2026 |
| Vanguard Group Inc | 7.92 | 8,914,065 | -18.7 | 12/31/2025 |
| UBS Group AG | 7.25 | 8,150,361 | +33.4 | 03/31/2026 |
| Rubicon Founders LLC | 5.17 | 5,816,123 | +0.0 | 03/31/2026 |
| Engaged Capital LLC | 4.95 | 5,563,912 | +0.0 | 03/31/2026 |
| D. E. Shaw & Co LP | 4.83 | 5,434,032 | +3.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.33 | 4,867,403 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.09 | 3,479,555 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.